• A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID
• A Nationwide Study of the Delayed Diagnosis and the Clinical Manifestations of Predominantly Antibody Deficiencies and <em>CTLA4</em>-Mediated Immune Dysregulation Syndrome in Greece
• A novel mutation in DNMT3B gene causing ICF1 syndrome in an infant with refractory thrombocytopenia
• A Novel Variant of the PIK3R1 Gene Mutation Associated With SHORT Syndrome and Agammaglobulinemia
• A phase II study of Bruton's tyrosine kinase inhibition for the prevention of anaphylaxis
• A prospective study of zanubrutinib, a Bruton tyrosine kinase inhibitor, in relapsed/refractory idiopathic multicentric Castleman disease
• Analysis of factors involved in the development of humoral response to vaccination against SARS-CoV-2 in patients with rheumatic pathology under biological treatment
• Antibody Deficiency in Patients with Biallelic KARS1 Mutations
• Antibody Response Before and After the Booster Dose of Inactivated Corona Vaccine in Antibody Deficient Patients
• Association between serum IgG concentrations and the incidence of infections in patients with chronic lymphocytic leukemia and secondary immunodeficiency under treatment with Privigen
• Baseline immunoglobulin G and immune function in non-Hodgkin lymphoma: a retrospective analysis
• Bruton tyrosine kinase inhibitors in multiple sclerosis: evidence and expectations
• Bruton's tyrosine kinase (BTK) inhibitors for the treatment of primary central nervous system lymphoma (PCNSL): current progress and latest advances
• Bruton's tyrosine kinase ablation inhibits B cell responses and antibody production for the prevention of chronic rejection in cardiac transplantation
• Bruton's tyrosine kinase as a promising therapeutic target for multiple sclerosis
• Bruton's tyrosine kinase inhibition ameliorated neuroinflammation during chronic white matter ischemia
• Bruton's Tyrosine Kinase Inhibitors in Refractory or Relapsing Primary Central Nervous System Lymphoma: A Meta-analysis and Systematic Review
• BTK drives neutrophil activation for sterilizing antifungal immunity
• BTK inhibitor-induced defects in human neutrophil effector activity against Aspergillus fumigatus are restored by TNF-α
• Case report of renal manifestations in X-linked agammaglobulinemia
• Case Report: Interindividual variability and possible role of heterozygous variants in a family with deficiency of adenosine deaminase 2: are all heterozygous born equals?
• Cellular immune response to SARS-CoV-2 in patients with primary antibody deficiencies
• Chronic Diarrhea with Villous Blunting of the Small Intestine Under Capsule Endoscopy in Common Variable Immunodeficiency and X-Linked Agammaglobulinemia: A Case Series
• Clinical and Immunologic Features of a Patient With Homozygous FNIP1 Variant
• Clinical efficacy of SARS-CoV-2 Omicron-neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency
• Clinical features and mutational analysis of X-linked agammaglobulinemia patients in Malaysia
• Combined Treatment of Progressive Encephalitis in an X-linked Agammaglobulinemia Patient
• COVID-19 Pneumonia with Migratory Pattern in Agammaglobulinemic Patients: A Report of Two Cases and Review of Literature
• CXCR4 WHIM syndrome is a cancer predisposition condition for virus-induced malignancies
• CXCR4: from B-cell development to B cell-mediated diseases
• Cytomegalovirus Infections in the Atypical Host: A Case Series of Clinical Conundra
• Deficient anterior pituitary with common variable immune deficiency (DAVID syndrome): a new case and literature reports
• Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL
• Early detection of WHIM symdrome. A case report
• Early infection risk in patients with systemic lupus erythematosus treated with rituximab or belimumab from the British Isles Lupus Assessment Group Biologics Register (BILAG-BR): a prospective longitudinal study
• Enhanced CD19 activity in B cells contributes to immunodeficiency in mice deficient in the ICF syndrome gene Zbtb24
• Evaluation of BMS-986142, a reversible Bruton's tyrosine kinase inhibitor, for the treatment of rheumatoid arthritis: a phase 2, randomised, double-blind, dose-ranging, placebo-controlled, adaptive design study
• First report of Wilson disease and Bruton agammaglobulinemia in the same patient caused by new mutations in <em>ATP7B</em> and <em>BTK</em> genes
• First-in-Human Study of the Reversible BTK Inhibitor Nemtabrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia and B-Cell Non-Hodgkin Lymphoma
• From variant of uncertain significance to likely pathogenic in two siblings with atypical RAG2 Deficiency: a case report and review of the literature
• Gene regulation in inborn errors of immunity: Implications for gene therapy design and efficacy
• Genetic screening in a Brazilian cohort with inborn errors of immunity
• Good syndrome and cytomegalovirus retinitis: A literature review
• Hemophagocytic inflammatory syndrome in ADA-SCID: report of two cases and literature review
• Human inborn errors of immunity associated with IRF4
• Hypogammaglobulinemia
• Hypogammaglobulinemia, a new risk factor for hepatitis B virus reactivation : about two cases
• IgA nephropathy in a child with X-linked agammaglobulinemia: a case report
• IgG replacement in multiple myeloma
• Immune Responses 6 Months After mRNA-1273 COVID-19 Vaccination and the Effect of a Third Vaccination in Patients with Inborn Errors of Immunity
• Immunodeficiency
• Immunogenicity of COVID-19 booster vaccination in IEI patients and their one year clinical follow-up after start of the COVID-19 vaccination program
• Immunoglobulin replacement vs prophylactic antibiotics for hypogammaglobulinemia secondary to hematological malignancy
• Impaired Response to Polysaccharide Vaccine in Selective IgE Deficiency
• In vivo Bruton's tyrosine kinase inhibition attenuates alcohol-associated liver disease by regulating CD84-mediated granulopoiesis
• In-depth blood immune profiling of Good syndrome patients
• Inborn Errors of Immunity-the Sri Lankan Experience 2010-2022
• Inhibitors of Bruton's tyrosine kinase as emerging therapeutic strategy in autoimmune diseases
• Intravenous immunoglobulins for the treatment of prolonged COVID-19 in immunocompromised patients: a brief report
• Investigation of a synonymous mutation in Btk in a patient with agammaglobulinemia: A case report
• Kawasaki Disease and Inborn Errors of Immunity: Exploring the Link and Implications
• Limitations in the clinical utility of vaccine challenge responses in the evaluation of primary antibody deficiency including Common Variable Immunodeficiency Disorders
• Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency
• Metagenomics assists in the diagnosis of a refractory, culture-negative pyoderma gangrenosum-like ulcer caused by Helicobacter cinaedi in a patient with primary agammaglobulinemia
• Mulibrey nanism and immunological complications: a comprehensive case report and literature review
• Multiplex Real-Time PCR-Based Newborn Screening for Severe Primary Immunodeficiency and Spinal Muscular Atrophy in Osaka, Japan: Our Results after 3 Years
• Non-infectious Pulmonary Complications in Children with Primary Immunodeficiency
• Persistent Hypogammaglobulinemia after Receiving Rituximab Post-HSCT Is Not Caused by an Intrinsic B Cell Defect
• Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency
• Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia
• Preclinical evidence for the effective use of TL-895, a highly selective and potent second-generation BTK inhibitor, for the treatment of B-cell malignancies
• Pulmonary Computed Tomography Screening Frequency in Primary Antibody Deficiency
• PULMONARY CT SCREENING FREQUENCY IN PRIMARY ANTIBODY DEFICIENCY
• Purine Nucleoside Phosphorylase Deficient Severe Combined Immunodeficiencies: A Case Report and Systematic Review (1975-2022)
• Quality of Life Evaluation in Saudi Arabian Pediatric Patients with Primary Immunodeficiency Diseases Receiving 20% Subcutaneous IgG Infusions at Home
• Recent advances in the treatment of primary and secondary progressive Multiple Sclerosis
• Recent research of BTK inhibitors: Methods of structural design, pharmacological activities, manmade derivatives and structure-activity relationship
• Role of Skewed X-Chromosome Inactivation in Common Variable Immunodeficiency
• Secondary hypogammaglobulinemia in adults-A large retrospective cohort study
• Severe enterovirus infections in patients with immune-mediated inflammatory diseases receiving anti-CD20 monoclonal antibodies
• Sustained response following BTK inhibitors based treatment in HIV-related primary central nervous system lymphoma: case report
• Synthesis and application of small molecules approved for the treatment of lymphoma
• Transcriptome profiling of regulatory T cells from children with transient hypogammaglobulinemia of infancy
• Transient Hypogammaglobulinemia of Infancy
• Unraveling the Natural History of Good's Syndrome: A Progressive Adult Combined Immunodeficiency
• Update on the management of relapsed/refractory chronic lymphocytic leukemia
• Who's your data? Primary immune deficiency differential diagnosis prediction via machine learning and data mining of the USIDNET registry
• X-Linked Agammaglobulinemia
• X-Linked Immunodeficiency
• X-Linked Lymphoproliferative Syndrome: A Spectrum of Clinical and Immunological Profile and Novel Pathogenic Variants from Chandigarh, India